By David Tuller, DrPH
Here are a few things I’ve recently read (or listened to).
The Freakonomics brand is well-known in the US. I didn’t realize there was a Freakonomics, M.D. podcast until I listened to this recent half-hour episode. The podcast is hosted by Dr Bapu Jena, a physician and economist at Harvard Medical School. The sub-head of this particular edition pretty much sums up the focus of the informative and thoughtful discussion: ”Chronic fatigue syndrome looks remarkably similar to Long Covid, but has been ignored by the medical community. Could patients finally get some answers to their debilitating illness?”
The conversation includes interviews with Anthony Komaroff, a long-time ME/CFS expert at Harvard; Ronald Davis, the Stanford geneticist whose son’s illness triggered his search for answers to the illness; and Vicky Whittemore, the National Institutes of Health program officer who overseas funding in this domain. While most of the information will likely be familiar to those immersed in the issue, the podcast definitely provides a clear overview of a great deal of key background material.
One statement by Whittemore, in which she linked lower funding levels to a perceived shortage of researchers or quality research proposals in the field, did raise some questions among patients, as this tweet indicates. The statement also irritated Janet Dafoe, who tweeted that her husband—Ron Davis—has submitted 24 applications in this domain, but only one was funded.
Guardian essay on giving up hope
Keith Kahn-Harris, a long-time ME/CFS patient, is also a sociologist who signed Virology Blog’s 2018 open letter to The Lancet about the PACE trial’s “unacceptable methodological lapses.” I first touched base with him after reading a Guardian article he wrote a few years ago called “Denialism: what drives people to reject the truth.” In a bit of an own goal, Professor Michael Sharpe, a lead PACE trial investigator who believes everyone who challenges the PACE trial is engaged in denialism, promoted the article on social media—apparently not realizing that Kahn-Harris himself has ME/CFS.
Last week, The Guardian published another article by Kahn-Harris, with this provocative heading: “I gave up hope of a cure for my chronic condition. And it’s made me happier than ever before.” After many years of illness, noted the author, he “embraced [his] identity as a person with a disability…I am not on a treadmill of trying new treatments. Maybe one day there will be a cure, or maybe not. Giving up hope has given me back the capacity for joy.”
The article drew both praise and criticism on social media. Some appreciated Kahn-Harris’ efforts to cope, empathized with his approach, or expressed related feelings. However, given that his case of ME/CFS is relatively moderate, others felt his piece provided an unbalanced portrait of the illness or might be taken to imply that all patients could choose to do as he has.
The author himself acknowledged the limitations of his argument with these key concluding paragraphs, in which he also attempted to draw a larger societal conclusion from his account:
“Yet here’s the kicker: hopelessness is a privilege. If my condition was just a bit more severe, my life would be miserable. If I wasn’t married and didn’t have a supportive family, I would be in penury. If I hadn’t chosen a career path that has some flexibility, I would be in a very difficult position.
“Giving up hope requires a safety net. The challenge for our society is to enable others with chronic conditions and disabilities to give up hope without giving up everything else.“
Psychiatrist Yochai Re’em on treating long Covid patients
In the spring of 2021, the Wall Street Journal published an odious opinion piece—“The Dubious Origins of Long Covid”–penned by Jeremy Devine, a psychiatric resident at McMaster University in Ontario, Canada. Dr Devine’s misogynistic, homophobic screed blasted “long Covid” as a patient-invented condition that was actually a form of mental illness driven by what he portrayed as a collective wave of hysteria. Shortly afterwards, the Wall Street Journal published a response from another young psychiatrist, Yochai Re’em—himself a long Covid sufferer and a member of a patient-led research group derided and belittled by Dr Devine.
Dr Re’em, who practices in New York, has recently written a touching follow-up piece in The Lancet. In his new article, he discusses his experiences working with long Covid patients in addressing some of the mental health concerns that afflict people with a poorly understood illness. Needless to say, Dr Re’em rejects the view that the long Covid phenomenon is largely a result of pandemic-related psychological and emotional distress rather than poorly understood pathophysiological processes .
Here’s a sample:
“Some [patients] told me they were hesitant to come to psychiatric treatment for fear their non-psychiatric symptoms will no longer be taken seriously. Indeed, this fear of dismissal is based on prior experiences they have had with other providers who have been quick to shoo them off, mistaking their anxiety and urgency for recovery as causative rather than a correlation, and tightly wrapping it up in a psychogenic bow.”